Skip to Content

1049 (Abacavir and Lamivudine 600 mg / 300 mg)

Pill with imprint 1049 is Yellow, Capsule-shape and has been identified as Abacavir and Lamivudine 600 mg / 300 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Abacavir/lamivudine is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Abacavir/lamivudine 600 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 1049

Abacavir and lamivudine 600 mg / 300 mg 1049

Abacavir and Lamivudine

Imprint
1049
Strength
600 mg / 300 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70771-1053

Get help with Imprint Code FAQs.

Related Images for "1049"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.